Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of KRAS wild-type metastatic colorectal cancer: Final results of a phase II open-label clinical trial
Data de publicación
2013Título da revista
EUROPEAN JOURNAL OF CANCER
Tipo de contido
Publicación de congreso